Type 2 diabetes Nutritional, Metabolic, Endocrine Type 2 diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adults with poorly controlled type 2 diabetes mellitus and who are registered at Dasman Institute and in the primary care centres affiliated to Dasman. Type 2 diabetes will be defined according to current World Health Organisation criteria. Poorly controlled diabetes will be defined as having at least one HbA1c value of > 8% in the preceding 12 months and at recruitment despite standard care defined as the offer of at least 2 diabetes clinic reviews in the same time period. 2. On diet and/or oral hypoglycaemic agents and/or once daily long acting insulin where glycaemic control is monitored by the HbA1c and not by regular self monitoring of blood glucose by patient. 3. Age 18-75 years to increase the representativeness of the sample and to be inclusive of all ages. 4. Fluent in spoken Arabic or English and have a reading age in Arabic or English of a minimum age 7 years. 5. Officially resident in Kuwait.
Exclusion criteria
Exclusion criteria: 1. Duration of type 2 diabetes less than 1 year as these patients are still coming to terms and adjusting to the diagnosis and the self care roles. 2. Women who are gestational or planning pregnancy as they have specialist diabetes care needs 3. People with severe mental illnesses such as psychosis, learning difficulties, dementia excluded from the medical records and by checklist from the physician. 4. People with advanced cancer or diabetes complications (renal failure as measured by ACR > 50, above ankle amputation, registered partially blind) or terminal conditions. 5. Inability or unwillingness of individual or legal guardian/representative to give written informed consent. 6. Multiple insulin doses regimens as this will increase the need for more clinical resources to provide a more intensive biofeedback service requiring more clinician support. The purpose of the M-and-M study is to test whether a stand-alone psychological intervention delivered in a virtual media with minimum clinical support can be effective as an adjunct to usual diabetes care. 7. People who do not have access to a mobile phone or the internet. 8. Individuals with another member of their household participating in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference in HbA1c from baseline to 12 months between the 2 arms | — |
Secondary
| Measure | Time frame |
|---|---|
| Difference from baseline to 12 months between the 2 arms in body mass index, physical activity, fasting lipids, and quality of life. We will also measure HbA1c at 6 months into the treatment to examine the rate of change in glycaemic control and to minimise attrition | — |
Countries
Kuwait